FdaApplication

ANDA 216524

Back to search

Identifiers

Properties

PropertyValue
applicant_namePADAGIS ISRAEL PHARMACEUTICALS LTD
application_typeANDA
approval_date2023-11-14

Products (5)

ProductActive ingredientStrengthDosage form
ESTRADIOLESTRADIOL0.1% (1.25GM/PACKET)GEL;TRANSDERMAL
ESTRADIOLESTRADIOL0.1% (0.75GM/PACKET)GEL;TRANSDERMAL
ESTRADIOLESTRADIOL0.1% (1GM/PACKET)GEL;TRANSDERMAL
ESTRADIOLESTRADIOL0.1% (0.5GM/PACKET)GEL;TRANSDERMAL
ESTRADIOLESTRADIOL0.1% (0.25GM/PACKET)GEL;TRANSDERMAL

5 products